0
New
New
2022
Clinical Risk Grouping Solutions Market

Clinical Risk Grouping Solutions Market

by Product (Data Visualization Tools, Data Analytics), by Deployment (Private Cloud, Public Cloud, Hybrid Cloud), by End User (Healthcare service providers, Helthcare payers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A08191
Pages: 290
Oct 2022 | 1972 Views
Author(s) : Prathmesh B , Onkar S
Tables: 146
Charts: 56
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

Clinical Risk Grouping Solutions Market Research, 2031

The global clinical risk grouping solutions market was valued at $0.4 billion in 2021 and is projected to reach $1.6 billion by 2031, growing at a CAGR of 14.6% from 2022 to 2031. The clinical risk grouping (CRG) solutions are a well-known system used for distinguishing and grouping individuals with the use of inpatient and ambulatory diagnosis and procedure codes, pharmaceutical records, and demographic data along with the functional health status to assign each individual to a specific risk group for future healthcare projections.

Clinical risk grouping (CRG) is a software that works on proficient clinical logic to bifurcate each patient into a specific risk group. It is a specific grouping mechanism organized by data and based on clinical evidence and implements a wide range of data including patient history, records, administrative data, and other data to identify people of various age groups including children, adults, and elderly ones. CRGs are primarily used to check health service utilization patterns, profile physician practice patterns, identify new disease patterns and incidences, keep track of chronic or congenital disease prevalence, risk adjustment for pricing and capitation, and many more. CRGs are patient-centric, concentrating on the total burden of diseases rather than one disease and suiting all populations. They are also used to predict future healthcare utilization and manage potentially preventable events to improve health status.

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the clinical risk grouping solutions market as there is the introduction of work from the home model in many businesses sector due to there is the implementation of lockdowns in many countries. In addition, there is an increase in demand for virtual access to data which drives the growth of the market. Thus, COVID-19 has a significant positive impact on the clinical risk grouping solutions market.

Clinical Risk Grouping Solutions Market

The growth of the clinical risk grouping solutions market is majorly driven by the increasing demand for quality healthcare services and solutions, increasing acceptance of mHealth and telehealth practices, surging demand for improved patient safety and patient care, and increasing government initiatives to promote healthcare IT. Furthermore, the rise in the integration of artificial intelligence (AI) for the development of advanced healthcare devices drives the growth of the Clinical Risk Grouping Solutions Market Size.

Furthermore, an increase in the prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases (CVD) and hypertension boosts the demand for advanced clinical risk grouping solutions. For instance, according to Pan American Health Organization (PAHO), in 2019, an estimated 2.0 million people died from cardiovascular diseases (CVD). Thus, the prevalence of chronic diseases drives the focus of key players toward developing artificial intelligence (AI) integrated medical devices. For instance, Medtronic, the U.S. leader in medical technology, received U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor (ICM). AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.

The increase in the acceptability of mHealth and telehealth services in the U.S. due to the outbreak of the COVID-19 pandemic acts as a key growth driver of the clinical risk grouping market. In addition, the surge in the number of smartphone users encourages key players to develop health software, which is anticipated to notably contribute toward the growth of the Clinical Risk Grouping Solutions Market Size. For instance, in 2020, approximately, 294.15 million population in the U.S. were using smartphones. Moreover, in June 2020, Philips, a global leader in health technology, entered into a collaboration with American Telemedicine Association (ATA) to further help the adoption of telehealth software, demonstrating telehealth software efficiency in the connecting care sector across acute, post-acute, and home care settings. Thus, all these factors collectively are expected to foster the Clinical Risk Grouping Solutions Market Growth.

The rise in the disease burden and upsurge in the geriatric population has escalated the demand for improved patient safety and patient care. Moreover, the availability of advanced healthcare information technologies for wireless monitoring and treatment of patients suffering from different chronic diseases, such as blood pressure, heart rate, and diabetes, is one of the major factors that boost the market growth. With the help of healthcare information technology (IT), telehealth, and telemedicine solution, chronic diseases can be controlled and prevented from becoming severe in nature. For instance, according to the U.S. Administration for Community Living (ACL 2020) report, in 2019, the population aged 65+ was 54.1 million. Moreover, the implementation of favorable healthcare reforms such as the U.S. Affordable Care Act (ACA) and telehealth initiatives boosts the growth of the healthcare sector and improves patient safety and patient care.

Furthermore, the Clinical Risk Grouping Solutions Market Trends such as the increase in the prevalence of chronic diseases such as hypertension, diabetes, and cancer boost the demand for advanced and safer treatments such as mHealth applications for blood pressure monitoring, patient health analyzing software, and telehealth services.

In recent years, IT has become an inevitable part of every business as it fosters innovation. Healthcare organizations face extraordinary challenges to improve quality, and access, reduce harm, and increase efficiency, which can be addressed by innovations. The government in the U.S. has taken several efforts to promote healthcare IT in various settings. For instance, in 2020, the American Medical Association supported the telehealth initiative to enhance healthcare access. Moreover, in June 2021, the Government of the U.S. invested $80 million in creating a new public health informatics & technology program. Thus, an increase in initiatives by the U.S. Government to integrate IT in the healthcare sector contributes toward the growth of the Clinical Risk Grouping Solutions Industry.

The healthcare IT market is segmented on the basis of product, deployment model, end user, and region. By product, the segment market is classified into data visualization tools and data analytics. The data visualization tools are divided into software, and services. Depending on the deployment model, the market is classified into private cloud, public cloud, and hybrid cloud. By end user, it is categorized into a healthcare service provider and healthcare payers.

The clinical risk grouping solutions market is segmented into Product, Deployment, and End User.

Depending on the product, the Data Visualization Tools segment dominated the Clinical Risk Grouping Solutions Market Share in 2020, and this trend is expected to continue during the forecast period, owing to increasing demand for patient safety and care. However, the data analytics segment is expected to witness considerable growth during the forecast period, due to the rise in demand for advanced analytics tools.

Clinical Risk Grouping Solutions Market
By Product

Your browser does not support the canvas element.

Data Visualization Tools segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Based on the deployment, the Private Cloud segment dominated the Clinical Risk Grouping Solutions Market Share in 2021, and this trend is expected to continue during the forecast period, owing to the rise in the number of private service providers, and facilities provided by service providers. However, the Hybrid Cloud segment is expected to witness considerable growth during the forecast period, due to the rise in demand for Hybrid Cloud Deployment models.

Clinical Risk Grouping Solutions Market
By Deployment

Your browser does not support the canvas element.

Private Cloud segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Depending on the end user, The Healthcare service providers segment dominated the market in 2021, and this trend is expected to continue during the Clinical Risk Grouping Solutions Market Forecast period, owing to the rise in the number of Healthcare service providers, and an increasing number of private service providers. However, the Healthcare payers segment is expected to witness considerable growth during the forecast period, due to the rise in demand for advanced healthcare IT services.

Clinical Risk Grouping Solutions Market
By End User

Your browser does not support the canvas element.

Healthcare service providers segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

North America garnered the major share in the nicotine replacement therapy market in 2021 and is expected to dominate the global market during the forecast period, owing to a rise in the incidence of tobacco-associated diseases, well-developed healthcare infrastructure, and the presence of key players. However, Asia-Pacific is expected to register significant growth, owing to a rise in the incidence of tobacco-driven diseases, improvements in the healthcare infrastructure, and the presence of a high population base.

Clinical Risk Grouping Solutions Market
By Region

2031
North America 
Europe
Asia-Pacific
LAMEA

North America region holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

The major companies profiled in the report include Cerner corporation, Microsoft corporation, Alibaba Group Holding Limited, IBM, Dundas Data Visualization, Inc, SAS, Klipfolio, Oracle Inc., Domo, Inc., Koch Industries, Qlik Technologies, Salesforce, SAP, Sisense, TIBCO, and Greenway.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical risk grouping solutions market analysis from 2021 to 2031 to identify the prevailing clinical risk grouping solutions market Opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the clinical risk grouping solutions market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global clinical risk grouping solutions market trends, key players, market segments, application areas, and market growth strategies.

Clinical Risk Grouping Solutions Market Report Highlights

Aspects Details
Market Size By 2031 USD 1.6 billion
Growth Rate CAGR of 14.6%
Forecast period 2021 - 2031
Report Pages 290
Product
  • Data Visualization Tools
    • Type
      • Software
      • services
  • Data Analytics
Deployment
  • Private Cloud
  • Public Cloud
  • Hybrid Cloud
End User
  • Healthcare service providers
  • Helthcare payers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Conduent Inc, 3M Corporation, Optum, Inc, Cerner Corporation, Nuance Communications, Health Catalyst, Inc, HBI Solutions, Johns Hopkins University, Lightbeam Health Solutions, Dynamic Healthcare Systems
 

Loading Table Of Content...


 
 

This section provides the opinions of the top-level CXOs in the clinical risk grouping solutions market. According to the CXOs, a clinical risk grouping solution is software that works on proficient clinical logic to bifurcate each patient into a specific risk group. It is a specific grouping mechanism organized by data and is based on clinical evidence and implements a wide range of data including patient history, records, administrative data, and other data to identify people of various age groups including children, adults, and elderly ones. 

Clinical risk grouping solutions include various types of products such as data visualization tools, data analytics, and risk reporting solutions. The factors such as an increase in the prevalence of chronic diseases, advancements in clinical risk grouping tools, and increasing concern for minimizing healthcare expenditure growth of the clinical risk grouping solutions market. In addition, an increase in the number of key players and a rise in the integration of artificial intelligence in healthcare are expected to contribute to the growth of the clinical risk grouping solutions market.

North America is expected to witness the highest growth, in terms of revenue, owing to the rise in the prevalence of chronic diseases, the presence of key players for the development of advanced clinical risk grouping solutions, and the high adoption of cloud-based deployment in the region.

However, data privacy and sharing challenges on data visualization tools platforms can hamper the market growth.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of the Clinical Risk Grouping Solutions market is $415 million in 2021.

A. The forecast period in the report is from 2022 to 2031.

A. North America is the largest regional market for Clinical Risk Grouping Solutions.

A. The market value of the Clinical Risk Grouping Solutions market in 2022 was $478.5 million.

A. The top companies that hold the market share in the Clinical Risk Grouping Solutions market are Cerner corporation, Microsoft corporation, Alibaba Group Holding Limited, IBM, Dundas Data Visualization, Inc, SAS, Klipfolio, Oracle Inc., Domo, Inc., Koch Industries, Qlik Technologies, Salesforce, SAP, Sisense, TIBCO and Greenway.

A. The base year for the report is 2021.

A. Yes, Clinical Risk Grouping Solutions companies are profiled in the report

A. Asia-Pacific is expected to register the highest CAGR of 15.7% from 2022 to 2031, owing to an increase in the prevalence of chronic disorders, the presence of key players, and the high population.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Clinical Risk Grouping Solutions Market

Start reading instantly.
This Report and over 19,667+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Library
    Membership

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers